Human LOXL2 CHO Stable Overexpression Lysate: 产品信息
This Human LOXL2 overexpression lysate was created in CHO Stable Cells and intented for use as a Western blot (WB) positive control. Purification of LOXL2 protein (Cat: 11664-H08S) from the overexpression lysate was verified.
CHO Stable Cells
A DNA sequence encoding the human LOXL2 (Q9Y4K0) (Met1-Gln774) was expressed, fused with a polyhistidine tag at the C-terminus.
The recombinant human LOXL2 consists of 760 amino acids and has a predicted molecular mass of 85.5 kDa.
Human LOXL2 CHO Stable Overexpression Lysate: 使用指南
Cell lysate was prepared by homogenization of the over-expressed cells in ice-cold modified RIPA Lysis Buffer with cocktail of protease inhibitors (Sigma). Cell debris was removed by centrifugation. Protein concentration was determined by Bradford assay (Bio-Rad protein assay, Microplate Standard assay). The cell lysate was boiled for 5 min in 1 x SDS loading buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% b-mercaptoethanol, and lyophilized.
1. Centrifuge the tube for a few seconds and ensure the pellet at the bottom of the tube.
2. Re-dissolve the pellet using 200μL pure water and boil for 2-5 min.
1 X Sample Buffer (1 X modified RIPA buffer+1 X SDS loading buffer).
稳定性 & 储存条件
Store at 4℃ for up to twelve months from date of receipt. After re-dissolution, aliquot and store at -80℃ for up to twelve months. Avoid repeated freeze-thaw cycles.
Western Blot (WB) Optimal dilutions/concentrations should be determined by the end user.
Human LOXL2 CHO Stable Overexpression Lysate: 别称
Human LOR2 Overexpression Lysate; Human Lysyl oxidase-like 2 Overexpression Lysate; Human WS9-14 Overexpression Lysate
Lysyl oxidase homolog 2, also known as Lysyl oxidase-like protein 2, Lysyl oxidase-related protein 2, Lysyl oxidase-related protein WS9-14 and LOXL2, is a secreted protein that belongs to the lysyl oxidase family. LOXL2 contains four SRCR domains. The lysyl oxidase family is made up of five members: lysyl oxidase (LOX) and lysyl oxidase-like 1-4 ( LOXL1, LOXL2, LOXL3, LOXL4 ). All members share conserved C-terminal catalytic domains that provide for lysyl oxidase or lysyl oxidase-like enzyme activity; and more divergent propeptide regions. LOX family enzyme activities catalyze the final enzymatic conversion required for the formation of normal biosynthetic collagen and elastin cross-links. LOXL2 is expressed by pre-hypertrophic and hypertrophic chondrocytes in vivo, and that LOXL2 expression is regulated in vitro as a function of chondrocyte differentiation. LOXL2 promotes chondrocyte differentiation by mechanisms that are likely to include roles as both a regulator and an effector of chondrocyte differentiation. LOXL2 expression could also be explored as a molecular target in the prevention of breast cancer progression.
lysyl oxidase-like 2
Peng,L. et al., 2009, Carcinogenesis. 30 (10):1660-9.
Hollosi,P. et al., 2009, Int J Cancer. 125 (2):318-27.
Rückert,F. et al., 2010, Int J Colorectal Dis. 25 (3):303-11.
Iftikhar,M. et al., 2011, J Biol Chem. 286 (2):909-18.